Navigation Links
New Taxotere(R) (docetaxel) Injection Concentrate Data to be Presented at the 30th Annual San Antonio Breast Cancer Symposium (SABCS)
Date:12/7/2007

Data with investigational Taxotere(R) regimens in the management of breast

cancer, across several disease stages, to be presented

BRIDGEWATER, N.J., Dec. 7 /PRNewswire-FirstCall/ -- Among the 62 oral abstracts accepted for presentation at the 30th annual San Antonio Breast Cancer Symposium (SABCS), six with Taxotere(R) (docetaxel) Injection Concentrate investigational regimens will be presented in plenary sessions.

-- Plenary Lecture 1 on the opening day of the symposium will review data

for systemic adjuvant therapies being investigated for the treatment

of breast cancer.

"The worldwide overview: New results for systemic adjuvant therapies." Peto R, Early Breast Cancer Trialists' Collaborative Group (EBCTCG), University of Oxford, UK.

Thursday, December 13, 2007, 8:55 AM / Plenary lecture 1, Exhibit Hall D

-- The data from studies with Taxotere(R)-based regimens and

anthracycline-based regimens will be discussed through two

presentations:

Abst 12: "Extended follow-up and analysis by age of the US Oncology Adjuvant trial 9735." Jones S, et al; US Oncology Research, Inc., Houston, TX.

Thursday, December 13, 2007, 9:45AM / Plenary lecture 1, Exhibit Hall D

This presentation includes the updated analysis (seven years median

follow-up) of a randomized trial comparing four cycles of a standard

anthracycline regimen, doxorubicin/cyclophosphamide (AC), to a non

anthracycline regimen, Taxotere(R)/cyclophosphamide (TC). New

findings regarding overall survival as well as the effect of age on

efficacy and safety will be presented.

Abst 13: "Role of anthracycline-based therapy in the adjuvant treatment of breast cancer: efficacy analyses determined by molecular subtypes of the disease." Slamon DJ, et al; Cancer International Research Group (CIRG), Edmonton, AB, Canada.

Thu
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Investigational New Drug Application for Fat Melting Injections Cleared by the FDA
2. HCV and HBV spreading more slowly among injection drug users in San Francisco
3. Microbiotic technology developed for microinjection of zebrafish embryos
4. Pill Equals Injection in Preventing Clots After Hip Replacement
5. Multiple corticosteroid injections in pregnant women may increase cerebral palsy
6. Consumer Safety Alert on Fat Dissolving Injections
7. FDA Expands VELCADE(R) (Bortezomib) for Injection Label for Patients with Multiple Myeloma
8. MultiVu Video Feed: FDA Approves DORIBAX(TM) (doripenem for injection) for the Treatment of Complicated Intra-abdominal and Complicated Urinary Tract Infections
9. Ultrasound-guided injections help ease chronic Achilles tendon pain
10. Purified Fish Oil Concentrates Offer Solution to Current Seafood Controversy for Pregnant and Breastfeeding Women!
11. Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... A new study in the American Journal of ... searches reveals a recurring pattern that could be leveraged ... from San Diego State University, the Santa Fe Institute, ... Google searches (searches that included the term healthy and ... U.S. from 2005 to 2012. They found that on ...
(Date:4/17/2014)... in non-cancerous prostate tissue may have nearly twice the ... no inflammation, according to results of a new study ... Center. , The link between persistent inflammation and cancer ... cancer those with a Gleason score between 7 ... aggressive and rapidly growing prostate cancers. , "What we,ve ...
(Date:4/17/2014)... to a study published today in PLOS Pathogens ... where malaria is common can mount an immune response ... to avoid repeated bouts of high fever and illness ... their bloodstream. The findings may help researchers develop future ... the malaria parasite. , Each year, approximately 200 million ...
(Date:4/17/2014)... MANHASSET, NY In a review published in the ... MD, president of The Feinstein Institute for Medical Research, ... the medical community,s approach to treating sepsis, ... 200,000 Americans. , Sepsis occurs when molecules released into ... inflammation throughout the body. Inflammation is necessary for maintaining ...
(Date:4/17/2014)... Il. (April 17, 2014) Doctors who treat ... called lymphangioleiomyomatosis (LAM) can face an agonizing treatment ... of the disease and help relieve shortness of ... transplants, and sirolimus can cause potentially fatal complications ... pulmonologist Dr. Daniel Dilling, medical director of Loyola ...
Breaking Medicine News(10 mins):Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... of The Royal Marsden Hospital Manual of Clinical Nursing ... format that organises 15 key chapters into four key ... on areas such as risk management and preparing patients ... from the world-renowned UK centre of excellence, the Manual ...
... HealthDay Reporter , SUNDAY, April 3 (HealthDay News) -- Diabetes ... suggests an increased risk of cancer can be added to that ... had an 8 percent increased risk of developing cancer generally, while ... of prostate cancer were excluded from the calculation. The risk ...
... 4 (HealthDay News) -- Taking aspirin even once per month, ... a marked drop in the risk of developing pancreatic cancer, ... was linked to a 26 percent reduction in the risk ... of heart disease, was associated with an even greater drop ...
... be assessed by examining the epithelial cells found in ... the AACR 102nd Annual Meeting 2011, held April 2-6. ... provide a personalized assessment of breast cancer risk, said ... veterinary and animal sciences at the University of Massachusetts ...
... Prostate cancer is the second leading cause of cancer-related death ... reduced the number of deaths from the disease. By ... risk for aggressive disease or diagnosis at a young age, ... screening approach. For that reason, scientists have been looking for ...
... (March 29, 2011) Medicare coverage and nationwide ... as virtual colonoscopy, has tripled in recent years, according ... Journal of the American College of Radiology ... produce a three-dimensional visualization that permits a thorough and ...
Cached Medicine News:Health News:Patient's journey format drives new edition of vital student nurse manual 2Health News:Patient's journey format drives new edition of vital student nurse manual 3Health News:Add Cancer to Health Risks of Diabetes: Study 2Health News:Add Cancer to Health Risks of Diabetes: Study 3Health News:Monthly Aspirin Use Linked to Lower Pancreatic Cancer Risk 2Health News:Monthly Aspirin Use Linked to Lower Pancreatic Cancer Risk 3Health News:Breast milk may provide a personalized screen of breast cancer risk 2Health News:MicroRNA variations associated with earlier prostate cancer diagnosis in African-American men 2Health News:Nationwide utilization of virtual colonoscopy triples, study suggests 2
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Global ... Systems -- Focus on End Users ... OBJECTIVES A drug delivery system ...
(Date:1/15/2014)... 15, 2014  A novel wearable injector slightly larger than an ... patients to self-inject prescription drugs in the large doses required ... diseases, autoimmune deficiencies, and genetic disorders.  An ... by 2018, according to analysts.   Many of these drugs will ...
(Date:1/14/2014)... Jan. 14, 2014 InformEx, North America,s ... high-value chemistry, will hold the 30 th edition of ... Convention Center from January 21-24. (Logo: ... top pharmaceutical, fine chemical and specialty chemical companies will take ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... Dornier Compact Delta lithotripsy system features real value ... systems shock source and C-arm are fully integrated ... risk of misalignment. The therapy head on the ... lateral and horizontal movement and can treat in ...
Used for male external catheterization due to urinary incontinence. The inflatable retention ring secures the catheter and can be easily deflated for removal. Supplied non-sterile. Reusable. Intended...
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
Medicine Products: